TOX drives TH1 CD4+ T cell effector function, anti-tumor immunity, and pathogenicity in autoimmune diseases
ATAC-seq analysis of TOX WT and TOX KO  transgenic (TCRSMARTA) CD4 T cells from tdLN of tumor-bearing mice at day 11 post transfer Overall design: Naïve TOX WT and KO TCRSMARTA CD4 T cells were transferred into B16-GP61 tumor-bearing hosts, and at 11 days post transfer, sorted from tdLN, and subjected to ATAC-sequencing